The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.
Jun 10, 2024
0
0
The US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot has been authorized against a disease other than COVID-19.
May 31, 2024
0
0
Reports of a rare nervous system disorder were "more common than expected" in older U.S. adults who got the new RSV vaccines, according to a Centers for Disease Control and Prevention report released Thursday that's similar ...
May 30, 2024
0
0
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, ...
May 21, 2024
0
0
